Synopsis Uterine leiomyomas are the prevalent benign gynecologic condition. Available treatment interventions are mostly surgical and invasive that is costly and time-consuming. This study aimed to determine the efficacy and safety of ulipristal acetate for the treatment of symptomatic uterine leiomyomas. This week’s “ MED FACT ” discusses a clinical trial from the Journal Of Obstetrics & Gynecology, “ Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial ”.
Authors: Simon AJ; Catherino W; Segars HJ et al. Key Takeaways: Ulipristal acetate may be useful for the management of Symptomatic uterine leiomyomas, especially for patients desiring uterine and fertility-sparing treatment. Objective: To assess efficacy and safety of ulipristal acetate for treatment of symptomatic uterine leiomyomas. Study Type: Multicenter, phase 3, double-blind,…
